An evaluation of the necessity of repeat testing of critical and dangerous values in a medical center in Taiwan.

IF 1
Chih-Wei Tseng, Jia-Bin Liao, Herng-Sheng Lee
{"title":"An evaluation of the necessity of repeat testing of critical and dangerous values in a medical center in Taiwan.","authors":"Chih-Wei Tseng, Jia-Bin Liao, Herng-Sheng Lee","doi":"10.1093/labmed/lmag037","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Routine repeat testing of critical laboratory values delays reporting, and its effectiveness lacks empirical evidence. This study investigated the impact of automated repeat testing on report accuracy and timeliness.</p><p><strong>Methods: </strong>This retrospective study of data from a large accredited medical center in Taiwan analyzed the occurrence rate, relative frequency, differences in repeat testing, and reporting delays of critical and dangerous values. Acceptable difference criteria were based on measurement uncertainty or College of American Pathologists criteria. Differences greater than the acceptable difference criteria were defined as \"large differences.\"</p><p><strong>Results: </strong>The occurrence rates of critical and dangerous values were 0.15% and 0.23%, respectively, with an acceptable difference rate of 99.57%. Large differences occurred at 0.39% (within the analytical measurement range [AMR]), 7.69% (above the AMR), and 0% (below the AMR). Repeated testing caused a median reporting delay of 10 to 33 minutes.</p><p><strong>Discussion: </strong>Repeat testing within the AMR is unnecessary. Values above the AMR require repeat testing, whereas values below the AMR warrant investigation of preanalytical errors. Targeted repeat testing policies can reduce reporting times, minimize reagent waste, and enhance patient safety.</p>","PeriodicalId":94124,"journal":{"name":"Laboratory medicine","volume":"57 4","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2026-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laboratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/labmed/lmag037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Routine repeat testing of critical laboratory values delays reporting, and its effectiveness lacks empirical evidence. This study investigated the impact of automated repeat testing on report accuracy and timeliness.

Methods: This retrospective study of data from a large accredited medical center in Taiwan analyzed the occurrence rate, relative frequency, differences in repeat testing, and reporting delays of critical and dangerous values. Acceptable difference criteria were based on measurement uncertainty or College of American Pathologists criteria. Differences greater than the acceptable difference criteria were defined as "large differences."

Results: The occurrence rates of critical and dangerous values were 0.15% and 0.23%, respectively, with an acceptable difference rate of 99.57%. Large differences occurred at 0.39% (within the analytical measurement range [AMR]), 7.69% (above the AMR), and 0% (below the AMR). Repeated testing caused a median reporting delay of 10 to 33 minutes.

Discussion: Repeat testing within the AMR is unnecessary. Values above the AMR require repeat testing, whereas values below the AMR warrant investigation of preanalytical errors. Targeted repeat testing policies can reduce reporting times, minimize reagent waste, and enhance patient safety.

台湾某医疗中心重复检测临界和危险值的必要性评估。
简介:常规重复检测关键实验室值延迟报告,其有效性缺乏经验证据。本研究调查了自动化重复测试对报告准确性和及时性的影响。方法:本研究回顾性分析台湾某大型医疗中心的资料,分析其发生率、相对频率、重复检测的差异,以及危重值和危险值的报告延迟。可接受的差异标准是基于测量不确定度或美国病理学家学院的标准。差异大于可接受的差异标准被定义为“大差异”。结果:临界值和危险值的发生率分别为0.15%和0.23%,可接受差异率为99.57%。差异较大,分别为0.39%(在分析测量范围[AMR]内)、7.69%(高于AMR)和0%(低于AMR)。重复测试导致报告延迟的中位数为10至33分钟。讨论:在AMR内重复测试是不必要的。高于AMR的值需要重复测试,而低于AMR的值需要调查分析前误差。有针对性的重复检测政策可以减少报告时间,最大限度地减少试剂浪费,并提高患者安全。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书